Prime Minister Narendra Modi launched the ambitious **HPV vaccination India** campaign on Saturday. This initiative targets approximately 1.15 crore girls aged 14 years annually across the country. Furthermore, the Union Health Ministry aims to offer the vaccine free of cost at designated government health facilities.

Clinical Impact of HPV Vaccination India

Cervical cancer remains the second most common cancer among women in India. According to GLOBOCAN 2022 data, the nation faces over 1.2 lakh new cases and nearly 80,000 deaths every year. Specifically, persistent infection with high-risk HPV types 16 and 18 causes more than 80 per cent of these cases. Consequently, the nationwide rollout of Gardasil 4 represents a decisive move in public health. This quadrivalent vaccine provides 93-100 per cent effectiveness in preventing cervical cancer caused by vaccine-covered HPV types.

Evidence for the Single-Dose Schedule

India’s approach aligns with updated global recommendations and expert guidance from the National Technical Advisory Group on Immunisation (NTAGI). In 2022, the World Health Organization concluded that a single-dose schedule provides protection comparable to two-dose schedules. Moreover, more than 90 countries are now implementing single-dose schedules to improve coverage and affordability. India now joins over 160 nations that have introduced this vaccination into their national immunisation schedules.

Logistics and Healthcare Provider Support

Designated sites like Ayushman Arogya Mandirs and district hospitals will host the vaccination sessions. Additionally, skilled healthcare teams will manage all sites under the supervision of trained medical officers. These facilities maintain functional cold chain points to ensure uncompromised vaccine quality. Notably, the Indian Medical Association and FOGSI have already trained over 30,000 doctors to support this mission through counselling. Parents must provide informed consent prior to administration during this voluntary campaign.

Frequently Asked Questions

Q1: Which age group does the national HPV campaign target?

The campaign specifically targets girls aged 14 years across all states and Union territories in India.

Q2: Is the single-dose vaccine safe and effective?

Yes, scientific evidence demonstrates that a single dose provides comparable protection to a two-dose schedule with 93-100% effectiveness against covered HPV types.

Q3: Where can parents access the vaccine for their daughters?

The vaccine is available free of cost at government health facilities, including primary health centres, community health centres, and district hospitals.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. Government to target 1.15 crore HPV vaccinations yearly: Health ministry - ETHealthworld


2. World Health Organization. Human Papillomavirus Vaccines: WHO Position Paper, December 2022.


3. International Agency for Research on Cancer. GLOBOCAN 2022: India Cancer Statistics and Burden.